Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Coronary Stents Pipeline Market Report Overview

A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. Its main goal is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature.

The coronary stents pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Coronary Drug-Eluting Stents

·       Coronary Bioabsorbable Stents

·       Coronary Bare Metal Stents

·       Coronary Covered Stents

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Canada

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       MDL

Leading Companies ·       Abbott Vascular Inc

·       Adcomp Technologies Inc.

·       Advanced Bifurcation Systems Inc

·       Aeon Bioscience

·       Albert Einstein College of Medicine

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Coronary Stents Pipeline Market Segments

The key segments in the coronary stents pipeline market are coronary drug-eluting stents, coronary bioabsorbable stents, coronary bare metal stents, and coronary covered stents. As of October 2024, coronary drug-eluting stents accounted for the highest number of pipeline products.

Coronary Stents Pipeline Market Analysis by Segments, 2024 (%)

Coronary Stents Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Coronary Stents Pipeline Market

Download a Free Report Sample

Coronary Stents Pipeline Market Segmentation by Territories

The key territories in the coronary stents pipeline market are the US, Europe, China, Japan, and Canada, among others. As of October 2024, the US accounted for the highest number of pipeline products.

Coronary Stents Pipeline Market Analysis by Territories, 2024 (%)

Coronary Stents Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Coronary Stents Pipeline Market

Download a Free Report Sample

Coronary Stents Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the coronary stents pipeline products market are PMA, CE, NMPA, Shonin, and MDL, among others. As of October 2024, PMA was the most followed pathway for pipeline products in the coronary stents market.

Coronary Stents Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Coronary Stents Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Coronary Stents Pipeline Market

Download a Free Report Sample

Coronary Stents Pipeline Market – Competitive Landscape

A few of the leading companies associated with the coronary stents pipeline market are:

  • Abbott Vascular Inc.
  • Adcomp Technologies Inc.
  • Advanced Bifurcation Systems Inc.
  • Aeon Bioscience
  • Albert Einstein College of Medicine


Abbott Vascular Inc: Headquartered in Santa Clara, California, the US, Abbott Vascular Inc,  a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valves, coronary dilatation catheters, coronary drug-eluting stents, coronary guide wires, and others.

Aeon Bioscience: Aeon Bioscience (Aeon Bioscience) is a developer of a drug-eluting stent designed to address the medical challenges in cardiac diseases. The company is headquartered in Birmingham, Alabama, the US.

Coronary Stents Pipeline Market Analysis by Companies, 2024

Coronary Stents Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Coronary Stents Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Coronary Stents Pipeline Market Segments Outlook (2024)

  • Coronary Drug-Eluting Stents
  • Coronary Bioabsorbable Stents
  • Coronary Bare-Metal Stents
  • Coronary Covered Stents

Coronary Stents Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • Canada

Coronary Stents Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Shonin
  • MDL

Scope

This report provides:

  • Extensive coverage of the coronary stents under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of coronary stents and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of coronary stents under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abbott Vascular Inc
Adcomp Technologies Inc.
Advanced Bifurcation Systems Inc
Aeon Bioscience
Albert Einstein College of Medicine
Amaranth Medical Inc
Arterius Ltd
Atrium Medical Corp
Axordia Ltd (Inactive)
B. Braun Melsungen AG
Bactiguard Holding AB
Bionext Biotech Products Ltd.
Biosensors International Group Ltd
Biosten, LLC
Biotronik AG
Biotronik SE & Co KG
Boston Scientific Corp
Cardionovum GmbH
Cardiorev Pte Ltd (Inactive)
Columbia University
Concept Medical Inc
Contego Medical LLC
Cordis US Corp
Cytograft Tissue Engineering Inc (Inactive)
DISA Vascular (Pty) Ltd
Elixir Medical Corp
Endomimetics LLC
Envision Scientific Pvt Ltd
Georgia Institute of Technology
Global Vascular Co Ltd
HangZhou HuaAn Biotechnology Co., Ltd.
Hangzhou Juzheng Medical Technology Inc
I.B.S. S.p.A.
Icon Interventional Systems, Inc.
ID Nest Medical SAS
InspireMD Inc
Intressa Vascular SA
Japan Stent Technology Co., Ltd.
JW Medical Systems Ltd
Kaneka Corp
Kyoto Medical Planning Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
MangoGen Pharma Inc
Manli Cardiology Ltd
Medinol Ltd
Medlogics Device Corp (Inactive)
Medtronic Plc
Meril Life Sciences Pvt Ltd
Miami Cardiovascular Innovations
Micell Technologies Inc
Michigan Technological University
MicroPort Scientific Corp
Minvasys SAS
MIV Therapeutics Inc
NanoCoeur, Inc.
Nanova, Inc
Neovasc Inc
Nesstent Ltd.
Nexeon MedSystems Inc
North Carolina State University
Northwestern University
NuVascular Technologies Inc
OrbusNeich
Palmaz Scientific Inc (Inactive)
Pediastent LLC
QualiMed Innovative Medizinprodukte GmbH
Qvanteq AG
Relisys Medical Devices Ltd
REVA Medical Inc
Rontis AG
S3V Vascular Technologies
Sahajanand Medical Technologies Pvt Ltd
Shandong Rientech Medical Tech Co Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai BIOMAGIC Medical Device Co Ltd
Shanghai Healing Medical Instruments Co Ltd
Shanghai MicroPort Medical Group Co Ltd
Shanghai MicroPort Rhythm MedTech Co Ltd
Sino Medical Sciences Technology Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stentys SA
Tepha Inc
Terumo Corp
Terumo Interventional Systems
TissueGen Inc
Translumina Therapeutics LLP
Tremedics Medical Devices LLC
TrendyMED Inc.
UAB Minority Health and Health Equity Research Center
University of Colorado
University of Florida
University of Galway
University of Michigan
University of Pittsburgh
University of Strathclyde
University of Utah
VahatiCor Inc
VasoTech Inc.
Viller Scientific LLC
Vital3D Technologies
Vornia Biomaterials Ltd
Xenogenics Corporation

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Coronary Stents Overview

3 Products under Development

3.1 Coronary Stents – Pipeline Products by Stage of Development

3.2 Coronary Stents – Pipeline Products by Segment

3.3 Coronary Stents – Pipeline Products by Territory

3.4 Coronary Stents – Pipeline Products by Regulatory Path

3.5 Coronary Stents – Pipeline Products by Estimated Approval Date

3.6 Coronary Stents – Ongoing Clinical Trials

4 Coronary Stents – Pipeline Products under Development by Companies

4.1 Coronary Stents Companies – Pipeline Products by Stage of Development

4.2 Coronary Stents – Pipeline Products by Stage of Development

5 Coronary Stents Companies and Product Overview

5.1 Abbott Vascular Inc Company Overview

5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Adcomp Technologies Inc. Company Overview

5.2.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.3 Advanced Bifurcation Systems Inc Company Overview

5.3.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Aeon Bioscience Company Overview

5.4.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview

5.5 Albert Einstein College of Medicine Company Overview

5.5.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.6 Amaranth Medical Inc Company Overview

5.6.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Arterius Ltd Company Overview

5.7.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.8 Atrium Medical Corp Company Overview

5.8.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

5.9 Axordia Ltd (Inactive) Company Overview

5.9.1 Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.10 B. Braun Melsungen AG Company Overview

5.10.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview

5.11 Bactiguard Holding AB Company Overview

5.11.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview

5.12 Bionext Biotech Products Ltd. Company Overview

5.12.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.13 Biosensors International Group Ltd Company Overview

5.13.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.14 Biosten, LLC Company Overview

5.14.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.15 Biotronik AG Company Overview

5.15.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview

5.16 Biotronik SE & Co KG Company Overview

5.16.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

5.17 Boston Scientific Corp Company Overview

5.17.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.18 Cardionovum GmbH Company Overview

5.18.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.19 Cardiorev Pte Ltd (Inactive) Company Overview

5.19.1 Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.20 Columbia University Company Overview

5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.21 Concept Medical Inc Company Overview

5.21.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Contego Medical LLC Company Overview

5.22.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

5.23 Cordis US Corp Company Overview

5.23.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview

5.24 Cytograft Tissue Engineering Inc (Inactive) Company Overview

5.24.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.25 DISA Vascular (Pty) Ltd Company Overview

5.25.1 DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.26 Elixir Medical Corp Company Overview

5.26.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

5.27 Endomimetics LLC Company Overview

5.27.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.28 Envision Scientific Pvt Ltd Company Overview

5.28.1 Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.29 Georgia Institute of Technology Company Overview

5.29.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.30 Global Vascular Co Ltd Company Overview

5.30.1 Global Vascular Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.31 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview

5.31.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.32 Hangzhou Juzheng Medical Technology Inc Company Overview

5.32.1 Hangzhou Juzheng Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.33 I.B.S. S.p.A. Company Overview

5.33.1 I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview

5.34 Icon Interventional Systems, Inc. Company Overview

5.34.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.35 ID Nest Medical SAS Company Overview

5.35.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview

5.36 InspireMD Inc Company Overview

5.36.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview

5.37 Intressa Vascular SA Company Overview

5.37.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

5.38 Japan Stent Technology Co., Ltd. Company Overview

5.38.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.39 JW Medical Systems Ltd Company Overview

5.39.1 JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.40 Kaneka Corp Company Overview

5.40.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview

5.41 Kyoto Medical Planning Co Ltd Company Overview

5.41.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.42 Lifetech Scientific (Shenzhen) Co Ltd Company Overview

5.42.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 MangoGen Pharma Inc Company Overview

5.43.1 MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Manli Cardiology Ltd Company Overview

5.44.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.45 Medinol Ltd Company Overview

5.45.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.46 Medlogics Device Corp (Inactive) Company Overview

5.46.1 Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.47 Medtronic Plc Company Overview

5.47.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Meril Life Sciences Pvt Ltd Company Overview

5.48.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.49 Miami Cardiovascular Innovations Company Overview

5.49.1 Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview

5.50 Micell Technologies Inc Company Overview

5.50.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.51 Michigan Technological University Company Overview

5.51.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview

5.52 MicroPort Scientific Corp Company Overview

5.52.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.53 Minvasys SAS Company Overview

5.53.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview

5.54 MIV Therapeutics Inc Company Overview

5.54.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.55 NanoCoeur, Inc. Company Overview

5.55.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.56 Nanova, Inc Company Overview

5.56.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview

5.57 Neovasc Inc Company Overview

5.57.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview

5.58 Nesstent Ltd. Company Overview

5.58.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.59 Nexeon MedSystems Inc Company Overview

5.59.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 North Carolina State University Company Overview

5.60.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

5.61 Northwestern University Company Overview

5.61.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

5.62 NuVascular Technologies Inc Company Overview

5.62.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.63 OrbusNeich Company Overview

5.63.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

5.64 Palmaz Scientific Inc (Inactive) Company Overview

5.64.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.65 Pediastent LLC Company Overview

5.65.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview

5.66 QualiMed Innovative Medizinprodukte GmbH Company Overview

5.66.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.67 Qvanteq AG Company Overview

5.67.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

5.68 Relisys Medical Devices Ltd Company Overview

5.68.1 Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.69 REVA Medical Inc Company Overview

5.69.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.70 Rontis AG Company Overview

5.70.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview

5.71 S3V Vascular Technologies Company Overview

5.71.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.72 Sahajanand Medical Technologies Pvt Ltd Company Overview

5.72.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.73 Shandong Rientech Medical Tech Co Ltd Company Overview

5.73.1 Shandong Rientech Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.74 Shanghai Bio-heart Biological Technology Co Ltd Company Overview

5.74.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.75 Shanghai BIOMAGIC Medical Device Co Ltd Company Overview

5.75.1 Shanghai BIOMAGIC Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.76 Shanghai Healing Medical Instruments Co Ltd Company Overview

5.76.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.77 Shanghai MicroPort Medical Group Co Ltd Company Overview

5.77.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.78 Shanghai MicroPort Rhythm MedTech Co Ltd Company Overview

5.78.1 Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.79 Sino Medical Sciences Technology Inc Company Overview

5.79.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

5.80 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.80.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.81 Stentys SA Company Overview

5.81.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview

5.82 Tepha Inc Company Overview

5.82.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview

5.83 Terumo Corp Company Overview

5.83.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

5.84 Terumo Interventional Systems Company Overview

5.84.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview

5.85 TissueGen Inc Company Overview

5.85.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.86 Translumina Therapeutics LLP Company Overview

5.86.1 Translumina Therapeutics LLP Pipeline Products & Ongoing Clinical Trials Overview

5.87 Tremedics Medical Devices LLC Company Overview

5.87.1 Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview

5.88 TrendyMED Inc. Company Overview

5.88.1 TrendyMED Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.89 UAB Minority Health and Health Equity Research Center Company Overview

5.89.1 UAB Minority Health and Health Equity Research Center Pipeline Products & Ongoing Clinical Trials Overview

5.90 University of Colorado Company Overview

5.90.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.91 University of Florida Company Overview

5.91.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

5.92 University of Galway Company Overview

5.92.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview

5.93 University of Michigan Company Overview

5.93.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.94 University of Pittsburgh Company Overview

5.94.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.95 University of Strathclyde Company Overview

5.95.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview

5.96 University of Utah Company Overview

5.96.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview

5.97 VahatiCor Inc Company Overview

5.97.1 VahatiCor Inc Pipeline Products & Ongoing Clinical Trials Overview

5.98 VasoTech Inc. Company Overview

5.98.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.99 Viller Scientific LLC Company Overview

5.99.1 Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview

5.100 Vital3D Technologies Company Overview

5.100.1 Vital3D Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.101 Vornia Biomaterials Ltd Company Overview

5.101.1 Vornia Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.102 Xenogenics Corporation Company Overview

5.102.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview

6 Coronary Stents- Recent Developments

6.1 Oct 15, 2024: TCT 2024: Elixir Medical to Present Clinical Outcomes on Two Transformative Platforms Designed to Advance Cardiovascular Disease Treatment and Intervention

6.2 Oct 09, 2024: Biotronik Receives Humanitarian Device Exemption (HDE) For PK Papyrus Covered Coronary Stent

6.3 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024

6.4 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

6.5 Sep 16, 2024: New Device Studied at Cedars-Sinai Means Fewer Heart Surgeries for Babies

6.6 Sep 11, 2024: Renata Medical Receives FDA 510(k) Clearance for Minima Stent System

6.7 Sep 03, 2024: Renata Medical Announces First Patient to Receive Minima Growth Stent Following FDA Approval

6.8 Sep 03, 2024: ICON to Present at the Baird 2024 Global Healthcare Conference

6.9 Sep 02, 2024: ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action

6.10 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.11 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.12 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.13 Aug 14, 2024: Asahi Intecc Announces Executive Leadership Transition

6.14 Aug 14, 2024: ICON Announces Appointment of New Chief Financial Officer

6.15 Aug 13, 2024: Elixir Medical to Present Late-Breaking One-Year Primary Outcomes from the 2,400 Patient INFINITY-SWEDEHEART Clinical Trial at ESC Congress 2024

6.16 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance

6.17 Jul 30, 2024: Voluntary Announcement Firesorb Bioresorbable Coronary Scaffold System Obtained Approval For Marketing from the NMPA

6.18 Jul 01, 2024: BIOTRONIK Introduces Expanded Maximum Diameter Dimensions for Orsiro Mission DES

6.19 Jul 01, 2024: ICON plc Schedules Second Quarter 2024 Earnings Conference Call | Business Wire

6.20 Jun 27, 2024: MicroPort Releases Latest Clinical Study Results for Firehawk at EuroPCR 2024

6.21 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.22 Jun 19, 2024: Elixir’s DynamX bioadaptor obtains FDA breakthrough designation

6.23 Jun 18, 2024: Elixir Medical’s DynamX Sirolimus-Eluting Coronary Bioadaptor System Granted FDA Breakthrough Device Designation for the Treatment of Symptomatic Ischemic Heart Disease

6.24 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024

6.25 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.26 Jun 04, 2024: ICON to Present at the Jefferies Global Healthcare Conference

6.27 May 15, 2024: Publication of the One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System

6.28 May 14, 2024: EuroPCR 2024: Late-Breaking Data Demonstrate Significant Clinical Advantage of Elixir Medical’s DynamX Bioadaptor Over Standard of Care Drug-Eluting Stent at Two Years

6.29 May 14, 2024: EuroPCR 2024: Elixir Medical’s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES

6.30 May 08, 2024: Biotronik SE Receives Additional Humanitarian Device Exemption (HDE) clearance for PK Papyrus Covered Coronary Stent

6.31 Apr 29, 2024: King Fahad Armed Forces Hospital Begins Trial of New Bioadaptive Angioplasty Procedure for Heart Disease Treatment

6.32 Apr 13, 2024: Biotronik SE & Co Receives Additional Humanitarian Device Exemption (HDE) Clearance for PK Papyrus Covered Coronary Stent

6.33 Mar 22, 2024: Elixir’s DynamX BTK System secures FDA breakthrough designation

6.34 Mar 21, 2024: Microport Completes Enrollment in Target First Trial with Firehawk Coronary Stent

6.35 Mar 18, 2024: FDA Breakthrough Device Designation for BIOTRONIK Freesolve™ Below-the-Knee Resorbable Magnesium Scaffold (RMS)

6.36 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.37 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.38 Feb 27, 2024: VahatiCor Announces Treatment of the First Patient with the A-FLUX Reducer System

6.39 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference

6.40 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.41 Jan 18, 2024: ivascular Announces First Enrollment in New Angiodapt Trial, an RCT of Abbreviated DAPT Post-stent Implantation in All-Comers

6.42 Jan 16, 2024: Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

6.43 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.44 Dec 18, 2023: Terumo India Advances Treatment Options for Heart Disease with the Launch of Ultimaster Nagomi

6.45 Dec 01, 2023: Potrero Medical Announces Restructuring and Continued Operations

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Coronary Stents – Pipeline Products by Stage of Development

Coronary Stents – Pipeline Products by Segment

Coronary Stents – Pipeline Products by Territory

Coronary Stents – Pipeline Products by Regulatory Path

Coronary Stents – Pipeline Products by Estimated Approval Date

Coronary Stents – Ongoing Clinical Trials

Coronary Stents Companies – Pipeline Products by Stage of Development

Coronary Stents – Pipeline Products by Stage of Development

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview

Second Generation Bioresorbable Vascular Scaffold – Product Status

Second Generation Bioresorbable Vascular Scaffold – Product Description

Xience Bioprime – Product Status

Xience Bioprime – Product Description

Xience Max – Product Status

Xience Max – Product Description

Xience SBA Everolimus Eluting Coronary Stent System – Product Status

Xience SBA Everolimus Eluting Coronary Stent System – Product Description

XIENCE Thinman DES – Product Status

XIENCE Thinman DES – Product Description

ZoMaxx Drug Eluting Coronary Stent System – Product Status

ZoMaxx Drug Eluting Coronary Stent System – Product Description

Abbott Vascular Inc – Ongoing Clinical Trials Overview

Xience SBA Everolimus Eluting Coronary Stent System – A Prospective, Multi-center, Single-blinded, Randomized Trial of the Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-II

Xience SBA Everolimus Eluting Coronary Stent System – Intracoronary Stenting and Restenosis – Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview

Dual Drug Eluting Stent – Product Status

Dual Drug Eluting Stent – Product Description

Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

ABS Stenting System – Drug Eluting Stent – Product Status

ABS Stenting System – Drug Eluting Stent – Product Description

Free-Standing Side-Branch Stenting System – Product Status

Free-Standing Side-Branch Stenting System – Product Description

Left Main Bifurcation Stenting System – Product Status

Left Main Bifurcation Stenting System – Product Description

Provisional Side-Branch Stenting System – Product Status

Provisional Side-Branch Stenting System – Product Description

Stenting System – Bare Metal Stent – Product Status

Stenting System – Bare Metal Stent – Product Description

Total Bifurcation Stenting System – Product Status

Total Bifurcation Stenting System – Product Description

Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Stent – Product Status

Drug Eluting Stent – Product Description

Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Stent – Product Status

Drug Eluting Stent – Product Description

Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

80-micron MAGNITUDE Bioresorbable Scaffold – Product Status

80-micron MAGNITUDE Bioresorbable Scaffold – Product Description

APTITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Status

APTITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Description

DEFIANCE Scaffold – Product Status

DEFIANCE Scaffold – Product Description

FORTITUDE Scaffold – Product Status

FORTITUDE Scaffold – Product Description

MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Status

MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold – Product Description

Second Generation FORTITUDE Scaffold – Product Status

Second Generation FORTITUDE Scaffold – Product Description

Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview

Arteriosorb Absorbable Drug-Eluting Scaffold – Product Status

Arteriosorb Absorbable Drug-Eluting Scaffold – Product Description

Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Super Flexible Cobalt Chromium Coronary Stent – Product Status

Next Generation Super Flexible Cobalt Chromium Coronary Stent – Product Description

Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Regenerative Stent – Product Status

Regenerative Stent – Product Description

B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview

Coroflex DEBlue – Product Status

Coroflex DEBlue – Product Description

Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview

Metal-Coated Vascular Stent – Product Status

Metal-Coated Vascular Stent – Product Description

Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Biostent – Product Status

Biostent – Product Description

Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

BioFreedom Ultra – Product Status

BioFreedom Ultra – Product Description

Sparrow Drug Eluting Stent System – Product Status

Sparrow Drug Eluting Stent System – Product Description

Biosensors International Group Ltd – Ongoing Clinical Trials Overview

BioFreedom Ultra – A Pilot Study Registry of the BioFreedom BA9 Ultra Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarct (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)

BioFreedom Ultra – A Post-Market Registry of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System

BioFreedom Ultra – A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System

BioFreedom Ultra – BioFreedom Ultra Stent in Hong Kong All Comers Registry

BioFreedom Ultra – Comparison of Polymer-free Cobalt-Chromium Thin Drug-coated Stents with Biodegradable Polymer Ultrathin Sirolimus-Eluting Stents and Prasugrel Monotherapy with Conventional 12-Month Dual Antiplatelet Therapy

BioFreedom Ultra – Evaluation of Effectiveness and Safety of Biofreedom Family Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

BioFreedom Ultra – Evaluation of Effectiveness and Safety of the First, Second, and New Drug-eluting Stents in Routine Clinical Practice

BioFreedom Ultra – P2Y12 Inhibitor-based Single Antiplatelet Therapy After a Short Dual Antiplatelet Therapy vs. Conventional Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Biofreedom ULTRA Polymer-free Drug-coated Stent for Unprotected Left Main Coronary Artery Disease (ULTRA-LM)

Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Endovascular Implant – Product Status

Biodegradable Endovascular Implant – Product Description

Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview

Coronary Stent System – Product Status

Coronary Stent System – Product Description

DREAMS 3G System – Product Status

DREAMS 3G System – Product Description

Magmaris Bioresorbable Magnesium Scaffold – Product Status

Magmaris Bioresorbable Magnesium Scaffold – Product Description

Biotronik AG – Ongoing Clinical Trials Overview

Magmaris Bioresorbable Magnesium Scaffold – Biotroniks – Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV

Magmaris Bioresorbable Magnesium Scaffold – Optical Coherence Guided Treatment of ST-segment Elevation Myocardial Infarction with the Drug-eluting Resorbable Magnesium Scaffold: The BEST- MAG Multicentre Study (Belgian ST-segment Elevation Myocardial Infarction Treatment with Resorbable Magnesium Scaffold)

Magmaris Bioresorbable Magnesium Scaffold – Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry)

Magmaris Bioresorbable Magnesium Scaffold – RMS (Resorbable Magnesium Scaffolds) Registry

Magmaris Bioresorbable Magnesium Scaffold – Scaffold Implantation in Emilia-Romagna

DREAMS 3G System – 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Drug Eluting Stents in Patients With Non ST-segment Elevation Acute Coronary Syndromes: the RESORB-ACS Randomized Clinical Trial

DREAMS 3G System – BIOTRONIK – Safety and Clinical Performance of the – Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries

DREAMS 3G System – BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial

Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

AMS-2 – Product Status

AMS-2 – Product Description

ProGenic Pimecrolimus-eluting Coronary Stent System – Product Status

ProGenic Pimecrolimus-eluting Coronary Stent System – Product Description

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Fully Resorbable Drug-Eluting Scaffold System – Product Status

Fully Resorbable Drug-Eluting Scaffold System – Product Description

JACTAX Drug Eluting Stent – Product Status

JACTAX Drug Eluting Stent – Product Description

SYNERGY – High Bleeding Risk – Product Status

SYNERGY – High Bleeding Risk – Product Description

SYNERGY 48 Stent – Product Status

SYNERGY 48 Stent – Product Description

TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System – Product Status

TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System – Product Description

Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview

Cardiosorb – Product Status

Cardiosorb – Product Description

DEBLIMUS – Product Status

DEBLIMUS – Product Description

PROTECT – Product Status

PROTECT – Product Description

ReNATURAL (M) – Product Status

ReNATURAL (M) – Product Description

ReNATURAL (P) – Product Status

ReNATURAL (P) – Product Description

Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Peptide-Eluting Coronary Stent – Product Status

Peptide-Eluting Coronary Stent – Product Description

Columbia University Pipeline Products & Ongoing Clinical Trials Overview

C3 Exoenzyme Coated Stent – Product Status

C3 Exoenzyme Coated Stent – Product Description

Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Abluminus DES+ – Product Status

Abluminus DES+ – Product Description

Concept Medical Inc – Ongoing Clinical Trials Overview

Abluminus DES+ – A Multicenter, Prospective, Study to Evaluate the Safety and Effcacy of the Abluminus DES+ in an All-Comers Population

Abluminus DES+ – ABILITY Diabetes Global

Abluminus DES+ – ABLUMINUS Below the Knee (BTK) Drug Eluting Stent (DES) Registry (ABLUMINUS BTK) – First in Men

Abluminus DES+ – Randomized Trial Investigating Clinical Outcomes of Two Sirolimus-Eluting Stents in Diabetes Mellitus

Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

CORGUARD Coronary Stent System – Product Status

CORGUARD Coronary Stent System – Product Description

Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview

Corio Pimecrolimus-Eluting Stent – Product Status

Corio Pimecrolimus-Eluting Stent – Product Description

Cypher Elite – Product Status

Cypher Elite – Product Description

NEVO Sirolimus-Eluting Coronary Stent – Product Status

NEVO Sirolimus-Eluting Coronary Stent – Product Description

Next Generation Coronary Stent – Product Status

Next Generation Coronary Stent – Product Description

SymBio Pimecrolimus/Paclitaxel-Eluting Stent – Product Status

SymBio Pimecrolimus/Paclitaxel-Eluting Stent – Product Description

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

LifeJacket Stent Graft – Coronary Stenting – Product Status

LifeJacket Stent Graft – Coronary Stenting – Product Description

DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview

Stellium Stent – Product Status

Stellium Stent – Product Description

Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System – Product Status

DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System – Product Description

DynamX Drug Eluting Coronary Bioadaptor System – Product Status

DynamX Drug Eluting Coronary Bioadaptor System – Product Description

Myolimus Eluting Coronary Stent – Durable Polymer – Product Status

Myolimus Eluting Coronary Stent – Durable Polymer – Product Description

Elixir Medical Corp – Ongoing Clinical Trials Overview

DynamX Drug Eluting Coronary Bioadaptor System – DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Novolimus Eluting Coronary Bioadaptor System (Bio-RESTORE)

DynamX Drug Eluting Coronary Bioadaptor System – DYNAMX Bioadaptor Implantation for the Treatment of Complex Coronary Lesions (DYNAMITE Study)

DynamX Drug Eluting Coronary Bioadaptor System – Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805

DynamX Drug Eluting Coronary Bioadaptor System – Infinity-swedeheart Study: Registry Based Randomized Clinical Trial (R-RCT) Comparing Long Term Outcomes of the DynamX Bioadaptor to the Resolute Onyx Stent in a More-comer PCI Patient Population

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Coronary Artery Stent – Product Status

Coronary Artery Stent – Product Description

Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Paclitaxel Eluting Stent – Product Status

Paclitaxel Eluting Stent – Product Description

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Smart Nanosensor-Embedded Stent – Product Status

Smart Nanosensor-Embedded Stent – Product Description

Global Vascular Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Stent Delivery System – Product Status

Drug-Eluting Stent Delivery System – Product Description

HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Xinsorb BRS – Product Status

Xinsorb BRS – Product Description

Hangzhou Juzheng Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

Coronary Natural Vascular Stent – Product Status

Coronary Natural Vascular Stent – Product Description

I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Stent – Product Status

Drug Eluting Stent – Product Description

Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Biosorb Pediatric Dissolving Stent – Product Status

Biosorb Pediatric Dissolving Stent – Product Description

ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview

ID Arterial System – Product Status

ID Arterial System – Product Description

InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview

MGuard Drug Eluting Stent – Product Status

MGuard Drug Eluting Stent – Product Description

Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview

Allay Aortic Stent – Product Status

Allay Aortic Stent – Product Description

Intressa Vascular SA – Ongoing Clinical Trials Overview

Allay Aortic Stent – Evaluation of the Safety and Performance of the Multilayer Flow Modulator (MFM) for the Treatment of Chronic Type B Aortic Dissection

Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Bioabsorbable Stent – Product Status

Bioabsorbable Stent – Product Description

JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview

Excel II DES – Product Status

Excel II DES – Product Description

Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview

MAHOROBA Stent – Product Status

MAHOROBA Stent – Product Description

Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Igaki-Tamai Coronary Stent – Product Status

Igaki-Tamai Coronary Stent – Product Description

Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – Product Status

IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – Product Description

Lifetech Scientific (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview

IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A Prospective, Multi-center, Single-arm Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-III

IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System – A Prospective, Multi-center, Single-blinded, Randomized Trial of the Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System in Patients with Coronary Artery Disease: IRONMAN-II

MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

Gene-Delivering Stent – Product Status

Gene-Delivering Stent – Product Description

Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview

Mirage – Product Status

Mirage – Product Description

Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview

IoNIR Ridaforolimus-Eluting Coronary Stent System – Product Status

IoNIR Ridaforolimus-Eluting Coronary Stent System – Product Description

Medinol Ltd – Ongoing Clinical Trials Overview

IoNIR Ridaforolimus-Eluting Coronary Stent System – IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

IoNIR Ridaforolimus-Eluting Coronary Stent System – IonMAN Trial-First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

COBRA-Q Drug Eluting Stent – Product Status

COBRA-Q Drug Eluting Stent – Product Description

SYNERGY – Product Status

SYNERGY – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Drug Filled Stent – Product Status

Drug Filled Stent – Product Description

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

MeRes100 – Product Status

MeRes100 – Product Description

Meril Life Sciences Pvt Ltd – Ongoing Clinical Trials Overview

MeRes100 – To Compare the Safety and Performance of MeRes100 Sirolimus Eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions

Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview

Biologically Engineered Stent – Product Status

Biologically Engineered Stent – Product Description

Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Bioresorbable Scaffold (BRS) – Product Status

Bioresorbable Scaffold (BRS) – Product Description

Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview

Bioabsorbable Stent – Product Status

Bioabsorbable Stent – Product Description

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Fantasy Drug-Eluting Stent – Product Status

Fantasy Drug-Eluting Stent – Product Description

Firebird Pro+ – Product Status

Firebird Pro+ – Product Description

Firebird2 Pro – Product Status

Firebird2 Pro – Product Description

Firefalcon Bioresorbable Device – Product Status

Firefalcon Bioresorbable Device – Product Description

Firehawk Plus – Product Status

Firehawk Plus – Product Description

Firesorb Bioresorbable Scaffold – Product Status

Firesorb Bioresorbable Scaffold – Product Description

MicroPort Scientific Corp – Ongoing Clinical Trials Overview

Firesorb Bioresorbable Scaffold – A Prospective Multicenter Single-arm Clinical Trial Assessing the Safety and Effectiveness of Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease: FUTURE III

Firehawk Plus – LARGE-ONE: A Prospective, Multicenter, Randomized Controlled Trial of the Use of Drug-coating Balloons(DCB) or Drug-eluting Stents(DES) in the Treatment of Large Diameter Coronary Atherosclerotic Lesions

Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview

Nile LM SIR Sirolimus Eluting Intracoronary Stent – Product Status

Nile LM SIR Sirolimus Eluting Intracoronary Stent – Product Description

MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Smart-1 DES – Product Status

Smart-1 DES – Product Description

Smart-2 DES – Product Status

Smart-2 DES – Product Description

Smart-3 DES – Product Status

Smart-3 DES – Product Description

Smart-4 DES – Product Status

Smart-4 DES – Product Description

Vestapor – Product Status

Vestapor – Product Description

VESTAsync – Product Status

VESTAsync – Product Description

NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Nanocoating Cardiac Stent – Product Status

Nanocoating Cardiac Stent – Product Description

Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview

Nanova Stent – Product Status

Nanova Stent – Product Description

Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview

Coronary Bifurcation Stent Delivery System – Product Status

Coronary Bifurcation Stent Delivery System – Product Description

Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview

NesStent’s Stent – Coronary Bifurcations – Product Status

NesStent’s Stent – Coronary Bifurcations – Product Description

Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview

PROTEX Coronary Stent System – Product Status

PROTEX Coronary Stent System – Product Description

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Metal Stent – Product Status

Biodegradable Metal Stent – Product Description

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

Liquid Cast Drug-Eluting Biodegradable Stent – Product Status

Liquid Cast Drug-Eluting Biodegradable Stent – Product Description

Liquid Drug Eluting Stent – Product Status

Liquid Drug Eluting Stent – Product Description

NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

NuSpun DE Stent Sheath – Product Status

NuSpun DE Stent Sheath – Product Description

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

Combo Plus CoCr – Product Status

Combo Plus CoCr – Product Description

Cura Stent – Product Status

Cura Stent – Product Description

Sirolimus-Eluting Absorbable Vascular Scaffold – Product Status

Sirolimus-Eluting Absorbable Vascular Scaffold – Product Description

Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Micro-Grooved Coronary Stent – Product Status

Micro-Grooved Coronary Stent – Product Description

Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview

Pediatric Bioresorbable Stent – Product Status

Pediatric Bioresorbable Stent – Product Description

QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Coronary Stent – Product Status

Biodegradable Coronary Stent – Product Description

Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

Qstent Coronary Stent System – Product Status

Qstent Coronary Stent System – Product Description

Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview

Corel + C Drug Eluting Stent – Product Status

Corel + C Drug Eluting Stent – Product Description

REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Status

Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Description

ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Status

ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold – Product Description

ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold – Product Status

ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold – Product Description

REVA Medical Inc – Ongoing Clinical Trials Overview

Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Expanded FANTOM II Clinical Study

Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Post Market Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold

Rontis AG Pipeline Products & Ongoing Clinical Trials Overview

Bifurcation Stent System – Product Status

Bifurcation Stent System – Product Description

S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview

3V Avatar – Product Status

3V Avatar – Product Description

Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Next-Generation Stent – Product Status

Next-Generation Stent – Product Description

Shandong Rientech Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Absorbable Zinc Alloy Drug Eluting Coronary Stent System – Product Status

Absorbable Zinc Alloy Drug Eluting Coronary Stent System – Product Description

Shandong Rientech Medical Tech Co Ltd – Ongoing Clinical Trials Overview

Absorbable Zinc Alloy Drug Eluting Coronary Stent System – Exploratory Study on the Safety and Effectiveness of Absorbable Zinc Alloy Drug-eluting Coronary Stent System

Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Bioheart BRS System – Product Status

Bioheart BRS System – Product Description

Bioheart Ultra BRS System – Product Status

Bioheart Ultra BRS System – Product Description

Shanghai Bio-heart Biological Technology Co Ltd – Ongoing Clinical Trials Overview

Bioheart BRS System – Study of Bioheart BRS System for the Treatment of Coronary Artery Disease

Shanghai BIOMAGIC Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

BIOMAGIC Biroresorbable Coronary Stent – Product Status

BIOMAGIC Biroresorbable Coronary Stent – Product Description

Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Biodegradable Sinus Stent – Product Status

Biodegradable Sinus Stent – Product Description

Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Firehawk Rapamycin Target Eluting Coronary Stent System – Product Status

Firehawk Rapamycin Target Eluting Coronary Stent System – Product Description

Shanghai MicroPort Medical Group Co Ltd – Ongoing Clinical Trials Overview

Firehawk Rapamycin Target Eluting Coronary Stent System – A Prospective, Multicenter, Single-arm Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in Patients with Coronary Artery Stenosis

Firehawk Rapamycin Target Eluting Coronary Stent System – Evaluation of a Modified Anti-Platelet Therapy Associated with Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated with Complete Revascularization Strategy

Firehawk Rapamycin Target Eluting Coronary Stent System – Evaluation of Effectiveness and Safety of the First, Second, and New Drug-eluting Stents in Routine Clinical Practice

Firehawk Rapamycin Target Eluting Coronary Stent System – LARGE-ONE: A Prospective, Multicenter, Randomized Controlled Trial of the Use of Drug-coating Balloons(DCB) or Drug-eluting Stents(DES) in the Treatment of Large Diameter Coronary Atherosclerotic Lesions

Shanghai MicroPort Rhythm MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Coronary Covered Stent System – Product Status

Coronary Covered Stent System – Product Description

Shanghai MicroPort Rhythm MedTech Co Ltd – Ongoing Clinical Trials Overview

Coronary Covered Stent System – A Prospective, Multicenter, Single-arm Trial of Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation

Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview

BuMA Supreme DES (Drug Eluting Stent) – Product Status

BuMA Supreme DES (Drug Eluting Stent) – Product Description

Supreme HT Drug-Eluting Stent – Product Status

Supreme HT Drug-Eluting Stent – Product Description

Sino Medical Sciences Technology Inc – Ongoing Clinical Trials Overview

BuMA Supreme DES (Drug Eluting Stent) – A Prospective, Multicenter Trial Program in China to Evaluate the Efficacy and Safety of BuMA Supreme (eG Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Patients with de Novo Coronary Lesions, OPC Trial

Supreme HT Drug-Eluting Stent – Non-inferiority of Angiography-derived Physiology Guidance Versus Usual Care in an All-comers PCI Population Treated with Unrestricted Use of the Healing-targeted Supreme (HT Supreme) Drug-eluting Stent and P2Y12 Inhibitor Monotherapy after 1-month of Dual-antiplatelet Therapy

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

Bare Metal Coronary Stent – Product Status

Bare Metal Coronary Stent – Product Description

TiN-Coated Coronary Stent – Product Status

TiN-Coated Coronary Stent – Product Description

Stentys SA Pipeline Products & Ongoing Clinical Trials Overview

STENTYS Paclitaxel-Eluting Stent – Product Status

STENTYS Paclitaxel-Eluting Stent – Product Description

Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview

TephaFLEX Absorbable Coronary Stent – Product Status

TephaFLEX Absorbable Coronary Stent – Product Description

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

Ultimaster Nagomi – Product Status

Ultimaster Nagomi – Product Description

Terumo Corp – Ongoing Clinical Trials Overview

Ultimaster Nagomi – A Post-Market Clinical Follow-up Study with Ultimaster Nagomi Sirolimus Eluting Coronary Stent System in Complex PCI Subjects

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold – Product Status

Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold – Product Description

Next Ultimaster Metallic Drug Eluting Stent – Product Status

Next Ultimaster Metallic Drug Eluting Stent – Product Description

TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview

Cardiovascular Stent – Product Status

Cardiovascular Stent – Product Description

Translumina Therapeutics LLP Pipeline Products & Ongoing Clinical Trials Overview

VIVO ISAR-Sirolimus Eluting Coronary Stent System – Product Status

VIVO ISAR-Sirolimus Eluting Coronary Stent System – Product Description

Translumina Therapeutics LLP – Ongoing Clinical Trials Overview

VIVO ISAR-Sirolimus Eluting Coronary Stent System – A Prospective, Open-Label, Multi-Country, Multicentre, Observational PoSt Market SurvEillance of VIVO ISAR (Polymer-Free Sirolimus Eluting Coronary Stent System) In Real World Patients Undergoing PCI With Short Dual Antiplatelet Therapy

VIVO ISAR-Sirolimus Eluting Coronary Stent System – A Prospective, Post Marketing Clinical Follow up Study to Evaluate the Safety and Performance of Polymer Free Sirolimus Eluting Coronary Stent System in Real World Indian Population

VIVO ISAR-Sirolimus Eluting Coronary Stent System – Multicenter Observatory Evaluating the Polymer-Free Sirolimus Eluting Coronary Stent System VIVO ISAR in Routine Clinical Practice (CELEBRITY Observatory)

VIVO ISAR-Sirolimus Eluting Coronary Stent System – Randomized, Controlled, Open-label, Double-blind, Multicenter Investig

Figures

Coronary Stents – Pipeline Products by Stage of Development

Coronary Stents – Pipeline Products by Segment

Coronary Stents – Pipeline Products by Territory

Coronary Stents – Pipeline Products by Regulatory Path

Coronary Stents – Pipeline Products by Estimated Approval Date

Coronary Stents – Ongoing Clinical Trials

Frequently asked questions

Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.